AvantBio Corporation Profile last edited on: 12/31/20
CAGE: 598F5
UEI:
Business Identifier: Bioscience, biomedicine, and chemistry products 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
2515 North East 104th Street
Vancouver, WA 98686
Vancouver, WA 98686
| (360) 433-8902 |
| avbusiness@avantbio.com |
| www.avantbio.com |
Location: Single
Congr. District: 03
County: Clark
Congr. District: 03
County: Clark
Public Profile
AvantBio Corporation develops bioscience, biomedicine, and chemistry products and processes for therapeutic, bioresearch, and chemical reagent markets. The firm is developing new chemically defined animal-free supplements and basal media formulations for primary human epithelial and corneal cells used in wound healing, corneal transplant, and cosmetic applications. AvantFluor is commercializing novel sulfur fluorine intermediates based on its novel patent pending chemical processes.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2010 | 1 | NIH | $100,000 | |
| Project Title: Cutaneous Polyionic Therapeutics | ||||
Key People / Management
Paul W Cook -- Co-founder, Chief Scientific and Executive Officer
Corey Jacklin -- Chief Business Development Officer
Rolf W Winter -- Co-founder, Vice President & Director of Chemistry R&D
Corey Jacklin -- Chief Business Development Officer
Rolf W Winter -- Co-founder, Vice President & Director of Chemistry R&D
Company News
There are no news available.
